(Q43631515)

25 November 2017

title

Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors (English)

1 reference

25 November 2017

1

1 reference

25 November 2017

J M Contreras

2

1 reference

25 November 2017

I Parrot

series ordinal

3

1 reference

25 November 2017

Y M Rival

series ordinal

4

1 reference

25 November 2017

C G Wermuth

series ordinal

5

1 reference

25 November 2017

publication date

1 May 2001

1 reference

Journal of Computer - Aided Molecular Design

25 November 2017

published in

1 reference

25 November 2017

volume

15

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

395-410

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1011150215288

25 November 2017

exact match

0 references

cites work

Comparative Molecular Field Analysis Using GRID Force-Field and GOLPE Variable Selection Methods in a Study of Inhibitors of Glycogen Phosphorylase b

1 reference

12 December 2020

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

12 December 2020

Scoring functions: a view from the bench

1 reference

12 December 2020

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

12 December 2020

Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs

1 reference

12 December 2020

Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors

1 reference

12 December 2020

Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

1 reference

12 December 2020

Evaluation of docking/scoring approaches: a comparative study based on MMP3 inhibitors.

1 reference

12 December 2020

Interaction of fluorescence probes with acetylcholinesterase. Site and specificity of propidium binding

1 reference

12 December 2020

Pharmacologic and Clinicopharmacologic Properties of SDZ ENA 713, a Centrally Selective Acetylcholinesterase Inhibitor

1 reference

12 December 2020

Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships.

1 reference

12 December 2020

Receptor-based 3D QSAR analysis of estrogen receptor ligands--merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods

1 reference

12 December 2020

Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors.

1 reference

12 December 2020

Trp279 is involved in the binding of quaternary ammonium at the peripheral site of Torpedo marmorata acetylcholinesterase

1 reference

12 December 2020

The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure

1 reference

12 December 2020

Automated docking of flexible ligands: applications of AutoDock

1 reference

12 December 2020

Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A

1 reference

12 December 2020

The effect of cholinesterase inhibitors on the secretion of APPS from rat brain cortex

1 reference

12 December 2020

Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors.

1 reference

12 December 2020

Alzheimer disease 1999: a status report.

1 reference

12 December 2020

Evaluation of proposed modes of binding of (2S)-2-[4-[[(3S)-1-acetimidoyl-3-pyrrolidinyl]oxy]phenyl]-3-(7-am idino- 2- naphthyl)propanoic acid hydrochloride and some analogs to factor Xa using a comparative molecular field analysis

1 reference

12 December 2020

[Morpholinoethylamino-3 methyl-4 phenyl-6 pyridazine dihydrochloride (Agar 1240)]

1 reference

12 December 2020

1 reference

12 December 2020

From molecular structure to Alzheimer therapy

1 reference

12 December 2020

Modelling of factor Xa-inhibitor complexes: a computational flexible docking approach

1 reference

12 December 2020

1 reference

12 December 2020

Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease

1 reference

12 December 2020

Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase

1 reference

12 December 2020

Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein

1 reference

12 December 2020

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

1 reference

12 December 2020

Aminopyridazines as acetylcholinesterase inhibitors

1 reference

12 December 2020

Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules

1 reference

12 December 2020

The biochemistry of Alzheimer disease.

1 reference

12 December 2020

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

12 December 2020

Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1011150215288

1 reference

journals/jcamd/SipplCPRW01

25 November 2017

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

Dimensions Publication ID

28 January 2021

1016432608

0 references

1 reference